These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15740411)

  • 21. AIDS vaccines. The first shot in a highly targeted strategy.
    Cohen J
    Science; 2004 Nov; 306(5700):1276-7. PubMed ID: 15550634
    [No Abstract]   [Full Text] [Related]  

  • 22. World AIDS Day 2007: AIDS at 26, are we there yet?
    Jeang KT
    Retrovirology; 2007 Dec; 4():86. PubMed ID: 18053150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The search for an HIV vaccine.
    Makgoba MW; Solomon N; Tucker TJ
    BMJ; 2002 Jan; 324(7331):211-3. PubMed ID: 11809644
    [No Abstract]   [Full Text] [Related]  

  • 24. HIV infections: the global epidemiology and goals for vaccine research.
    Ippolito G; Rezza G; Girardi E; Malkovsky M; Cairns JS
    Mol Med; 2000 Feb; 6(2):69-85. PubMed ID: 10859024
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of an AIDS vaccine: perspective from the South African AIDS Vaccine Initiative.
    Tucker TJ; Mazithulela G
    BMJ; 2004 Aug; 329(7463):454-6. PubMed ID: 15321907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical challenges of HIV vaccine trials in less developed nations: conflict and consensus in the international arena.
    Bayer R
    AIDS; 2000 May; 14(8):1051-7. PubMed ID: 10853988
    [No Abstract]   [Full Text] [Related]  

  • 27. [AIDS vaccines: promises and reality].
    Goudsmit J
    Ned Tijdschr Geneeskd; 2001 Jun; 145(26):1241-5. PubMed ID: 11455689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eureka! Success of combo HIV vaccine raises hopes, should revitalize research. An HIV vaccine shows surprising efficacy in human trials.
    AIDS Alert; 2009 Nov; 24(11):121-3. PubMed ID: 19960605
    [No Abstract]   [Full Text] [Related]  

  • 29. Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.
    Ferrantelli F; Buttò S; Cafaro A; Wahren B; Ensoli B
    Springer Semin Immunopathol; 2006 Nov; 28(3):289-301. PubMed ID: 16983452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS vaccine research in Asia: needs and opportunities. Report from a UNAIDS/WHO/NIID meeting Tokyo, 28-30 October 1998.
    AIDS; 1999 Jul; 13(11):UNAIDS 1-UNAIDS 13. PubMed ID: 10449273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicine. The need for a global HIV vaccine enterprise.
    Klausner RD; Fauci AS; Corey L; Nabel GJ; Gayle H; Berkley S; Haynes BF; Baltimore D; Collins C; Douglas RG; Esparza J; Francis DP; Ganguly NK; Gerberding JL; Johnston MI; Kazatchkine MD; McMichael AJ; Makgoba MW; Pantaleo G; Piot P; Shao Y; Tramont E; Varmus H; Wasserheit JN
    Science; 2003 Jun; 300(5628):2036-9. PubMed ID: 12829768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A brief history of the global effort to develop a preventive HIV vaccine.
    Esparza J
    Vaccine; 2013 Aug; 31(35):3502-18. PubMed ID: 23707164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Designing an AIDS vaccine.
    Laurence J
    AIDS Patient Care STDS; 2001 Sep; 15(9):449-51. PubMed ID: 11587629
    [No Abstract]   [Full Text] [Related]  

  • 34. US and Thai Governments defend HIV/AIDS vaccine trial in Thailand.
    Agnew B
    Bull World Health Organ; 2004 Mar; 82(3):231. PubMed ID: 15112014
    [No Abstract]   [Full Text] [Related]  

  • 35. Preparations for AIDS vaccine evaluations. AIDS International Training and Research Program.
    Bridbord K
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S227-9. PubMed ID: 7865307
    [No Abstract]   [Full Text] [Related]  

  • 36. An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic.
    Fauci AS
    JAMA; 2017 Oct; 318(16):1535-1536. PubMed ID: 29052689
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccine news from the 12th World AIDS Conference.
    Mirken B
    BETA; 1998 Oct; ():26-9. PubMed ID: 11365985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The complex challenges of HIV vaccine development require renewed and expanded global commitment.
    Bekker LG; Tatoud R; Dabis F; Feinberg M; Kaleebu P; Marovich M; Ndung'u T; Russell N; Johnson J; Luba M; Fauci AS; Morris L; Pantaleo G; Buchbinder S; Gray G; Vekemans J; Kim JH; Levy Y; Corey L; Shattock R; Makanga M; Williamson C; Dieffenbach C; Goodenow MM; Shao Y; Staprans S; Warren M; Johnston MI
    Lancet; 2020 Feb; 395(10221):384-388. PubMed ID: 31806257
    [No Abstract]   [Full Text] [Related]  

  • 39. Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.
    Ross AL; Bråve A; Scarlatti G; Manrique A; Buonaguro L
    Lancet Infect Dis; 2010 May; 10(5):305-16. PubMed ID: 20417413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Return to the lab for HIV vaccine research, say experts.
    Nierengarten MB
    Lancet Infect Dis; 2008 May; 8(5):282. PubMed ID: 18499904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.